News
Symbiosis secures £1 million of growth finance from Allied Irish Bank (GB)
Symbiosis Pharmaceutical Services has secured £1million of finance from Allied Irish Bank (GB) to support its 2020 growth strategy.
Symbiosis provides niche, sterile manufacturing services to global biotechnology and pharmaceutical company clients that are developing novel drug therapies and vaccines...
News
Softbox introduces eco-packaging solution for the pharma cold chain industry
Softbox, a leading global innovator and provider of temperature control packaging solutions for the pharmaceutical, life science and cold chain logistic industries announced the launch of Tempcell™ ECO, a new curbside-recyclable temperature control parcel shipper.
Tempcell™ ECO is made from...
News
Announcing New QuickSTAT Podcast – Life Science Logistics in a Life-changing World
The Quick Group has just launched another episode of their QuickConversations podcast, designed to help the life science and medical research community keep their global clinical trials moving during the pandemic – utilizing best practices and proven patient-centric solutions.
The...
News
Avalon GloboCare Achieves Milestones in Advancing Novel Intranasal and Oral COVID-19 Vaccine Candidate
Avalon GloboCare Corp., a clinical-stage global developer of cell-based technologies and therapeutics, announced a strategic partnership with the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria to develop an S-layer vaccine that can be administered by...
News
Roche improves speed and accuracy of non-small cell lung cancer diagnosis with launch of automated digital pathology algorithm
Roche announced the CE-IVD launch of its automated digital pathology algorithm, the uPath PD-L1 (SP263) image analysis for non-small cell lung cancer (NSCLC). The algorithm provides pathologists with automated assessments of scanned slide images that are objective and reproducible...
News
Gilead sets Covid-19 drug candidate remdesivir price at $390 per vial
Gilead Sciences has set the price of its investigational Covid-19 drug remdesivir at $390 per vial for the US and governments of other developed countries.
Current treatment patterns reveal that most patients may require a five-day treatment course, which involves...
Clinical Trials
Astrazeneca: Selumetinib granted orphan drug designation in Japan for neurofibromatosis type 1
AstraZeneca announced that selumetinib has been granted orphan drug designation (ODD) in Japan for the treatment of neurofibromatosis type 1 (NF1), a rare and debilitating genetic disease.
Selumetinib is co-developed and co-commercialised with MSD Inc., Kenilworth, N.J., US (MSD: known...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read